Instrument Inactif

Autres langues INSTEM

Actions

Instem and Proscia Partners to Accelerate Preclinical Development with Digital Pathology	17/06
Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline	25/01
Instem Delists from London Bourse's AIM After Merger with ArchiMed	21/11
France's Archimed Completes Acquisition of UK's Instem	20/11
Instem plc Announces Board Resignations	20/11
ArchiMed SAS agreed completed the acquisition of Instem plc (AIM : INS) from group of sellers.	20/11
Instem acquisition by Ichor sanctioned by UK court	16/11
Instem : Issue of Equity, PDMR Dealings and Rule 2.9 Announcement	16/11
UK Court Clears Archimed’s Takeover of Instem	16/11
Samson Rock Capital LLP - Form 8.3 - Instem Plc	15/11
Samson Rock Capital LLP - Form 8.3 - Instem Plc	13/11
Samson Rock Capital LLP - Form 8.3 - Instem Plc	10/11
Samson Rock Capital LLP - Form 8.3 - Instem Plc	09/11
Actual Experience appoints administrators	07/11
Instem's Acquisition by Archimed's Ichor Management Granted UK Regulatory Nod	07/11
Samson Rock Capital LLP - Form 8.3 - Instem Plc	06/11
Instem shareholders back motions relating to Archimed offer	03/11
Samson Rock Capital LLP - Form 8.3 - Instem Plc	03/11
Instem, Archimed’s Ichor Management Agree Acquisition Deal Price	30/10/23
Instem : Adjournment of the Court Meeting and General Meeting	20/10/23

Aucun résultat pour cette recherche